4 Conclusions While significant progress has been made in understanding the therapeutic potential of probiotics for NAFLD, several limitations persist in the current body of research
Gradual dose escalation and patient counseling may improve tolerability, particularly when initiating GLP-1 receptor agonist therapy [38, 43]
Insurance companies may not cover semaglutide for biweekly dosing
Vitamin C (ascorbic acid or ascorbate) can be converted to oxalates but the biochemical conversion system is saturated at low levels of vitamin C so that no additional oxalate is formed until very large doses (greater than 4 g per day) are consumed
Retatrutide (research grade), also designated LY3437943, is a long-acting synthetic peptide engineered to co-engage three distinct G-protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)